NCF2 and metabolic dysfunction-associated steatohepatitis: These results demonstrate that H2Kb restricted peptide Ncf2 can activate both hepatic and splenic CD8+ T cells from NASH mice in vitro and with increased activation, proliferation, and cytotoxicity.